The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded alternatives have raised critical questions ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

The Washington Examiner prides itself on its in-depth, enterprise, and investigative reporting. Here is a summary of our weekly series in 2024.

On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for ...

On January 8, 2025, the Department of Justice (“DOJ”) published its Final Rule to implement President Biden’s Executive Order 14117, ...

Ninety-six percent of online pharmacies were found to violate the law, meaning they were operating without a license and ...